Close Menu

NEW YORK – The US Food and Drug Administration said on Friday it has added a template to its website intended to facilitate submission of requests for Emergency Use Authorization of at-home sample collection kits for molecular diagnostic testing to detect SARS-CoV-2.

The template describes the data and information that labs and commercial manufacturers should submit for EUA of collection kits or tests with a home self-collection component.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.